Cargando…

Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial

AIMS: Mental health-related stigma is a major challenge associated with the huge mental health treatment gap. It has remained unclear what kind of educational content is effective in reducing the stigma. Whether biomedical messages (BMM) about mental illness are effective or harmful in decreasing st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojio, Yasutaka, Yamaguchi, Sosei, Ohta, Kazusa, Ando, Shuntaro, Koike, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061129/
https://www.ncbi.nlm.nih.gov/pubmed/31753045
http://dx.doi.org/10.1017/S2045796019000714
_version_ 1783681503516950528
author Ojio, Yasutaka
Yamaguchi, Sosei
Ohta, Kazusa
Ando, Shuntaro
Koike, Shinsuke
author_facet Ojio, Yasutaka
Yamaguchi, Sosei
Ohta, Kazusa
Ando, Shuntaro
Koike, Shinsuke
author_sort Ojio, Yasutaka
collection PubMed
description AIMS: Mental health-related stigma is a major challenge associated with the huge mental health treatment gap. It has remained unclear what kind of educational content is effective in reducing the stigma. Whether biomedical messages (BMM) about mental illness are effective or harmful in decreasing stigma is controversial. To investigate whether BMM can improve practically useful knowledge of mental illness, comparably to recommended messages (RCM) advocated by experts, of types such as ‘recovery-oriented’, ‘social inclusion/human rights’ and ‘high prevalence of mental illnesses’ through a randomised controlled trial (RCT). METHOD: This study is an individual-level RCT with a parallel-group design over 1 year, conducted in Tokyo, Japan. A total of 179 participants (males n = 80, mean age = 21.9 years and s.d. = 7.8) were recruited in high schools and universities, and through a commercial internet advertisement in June and July 2017, without any indication that the study appertained to mental health. Participants were allocated to the BMM and RCM groups. They underwent a 10-min intervention, and completed self-report questionnaires during baseline, post-test, 1-month follow-up and 1-year follow-up surveys. The primary outcome measures were practically useful knowledge of mental illness at the post-test survey using the Mental Illness and Disorder Understanding Scale (MIDUS). Analysis was conducted in October 2018. RESULTS: Both groups demonstrated improved MIDUS score in the post-test survey, and showed similar intervention effects (F((1, 177)) = 160.5, p < 0.001, η(2) = 0.48). The effect of the interventions continued until the 1-year follow-up survey (B [95% CI] = −2.56 [−4.27, −0.85], p < 0.01), and showed no difference between groups. The reported adverse effect that BMM increase stigma was not confirmed. CONCLUSIONS: BMM may have a positive impact on stigma, comparable to RCM. These findings may encourage reconsideration of the content of messages about mental health, as it is indicated that combining BMM and RCM might contribute to an effective anti-stigma programme.
format Online
Article
Text
id pubmed-8061129
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-80611292021-05-04 Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial Ojio, Yasutaka Yamaguchi, Sosei Ohta, Kazusa Ando, Shuntaro Koike, Shinsuke Epidemiol Psychiatr Sci Original Articles AIMS: Mental health-related stigma is a major challenge associated with the huge mental health treatment gap. It has remained unclear what kind of educational content is effective in reducing the stigma. Whether biomedical messages (BMM) about mental illness are effective or harmful in decreasing stigma is controversial. To investigate whether BMM can improve practically useful knowledge of mental illness, comparably to recommended messages (RCM) advocated by experts, of types such as ‘recovery-oriented’, ‘social inclusion/human rights’ and ‘high prevalence of mental illnesses’ through a randomised controlled trial (RCT). METHOD: This study is an individual-level RCT with a parallel-group design over 1 year, conducted in Tokyo, Japan. A total of 179 participants (males n = 80, mean age = 21.9 years and s.d. = 7.8) were recruited in high schools and universities, and through a commercial internet advertisement in June and July 2017, without any indication that the study appertained to mental health. Participants were allocated to the BMM and RCM groups. They underwent a 10-min intervention, and completed self-report questionnaires during baseline, post-test, 1-month follow-up and 1-year follow-up surveys. The primary outcome measures were practically useful knowledge of mental illness at the post-test survey using the Mental Illness and Disorder Understanding Scale (MIDUS). Analysis was conducted in October 2018. RESULTS: Both groups demonstrated improved MIDUS score in the post-test survey, and showed similar intervention effects (F((1, 177)) = 160.5, p < 0.001, η(2) = 0.48). The effect of the interventions continued until the 1-year follow-up survey (B [95% CI] = −2.56 [−4.27, −0.85], p < 0.01), and showed no difference between groups. The reported adverse effect that BMM increase stigma was not confirmed. CONCLUSIONS: BMM may have a positive impact on stigma, comparable to RCM. These findings may encourage reconsideration of the content of messages about mental health, as it is indicated that combining BMM and RCM might contribute to an effective anti-stigma programme. Cambridge University Press 2019-11-22 /pmc/articles/PMC8061129/ /pubmed/31753045 http://dx.doi.org/10.1017/S2045796019000714 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ojio, Yasutaka
Yamaguchi, Sosei
Ohta, Kazusa
Ando, Shuntaro
Koike, Shinsuke
Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
title Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
title_full Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
title_fullStr Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
title_full_unstemmed Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
title_short Effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
title_sort effects of biomedical messages and expert-recommended messages on reducing mental health-related stigma: a randomised controlled trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061129/
https://www.ncbi.nlm.nih.gov/pubmed/31753045
http://dx.doi.org/10.1017/S2045796019000714
work_keys_str_mv AT ojioyasutaka effectsofbiomedicalmessagesandexpertrecommendedmessagesonreducingmentalhealthrelatedstigmaarandomisedcontrolledtrial
AT yamaguchisosei effectsofbiomedicalmessagesandexpertrecommendedmessagesonreducingmentalhealthrelatedstigmaarandomisedcontrolledtrial
AT ohtakazusa effectsofbiomedicalmessagesandexpertrecommendedmessagesonreducingmentalhealthrelatedstigmaarandomisedcontrolledtrial
AT andoshuntaro effectsofbiomedicalmessagesandexpertrecommendedmessagesonreducingmentalhealthrelatedstigmaarandomisedcontrolledtrial
AT koikeshinsuke effectsofbiomedicalmessagesandexpertrecommendedmessagesonreducingmentalhealthrelatedstigmaarandomisedcontrolledtrial